Print Friendly, PDF & Email

NCT/Study#

NCT02732275 /

DS3201-A-J101

A Phase 1 Multiple Ascending Dose Study Of DS-3201b In Subjects With Lymphomas

DISEASE GROUP:

Lymphoma

current phase:

Phase I

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587